This inventor holds 7 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Columbia University, Other. Active years: 2010-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 2,554 
1 out of 834,513 Years Active: 2010-2024
Title: Antonio Iavarone: Innovator in Oncogenic Fusion Proteins
Introduction
Antonio Iavarone is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the development of oncogenic fusion proteins. With a total of 7 patents to his name, Iavarone's work has the potential to impact the treatment of gene-fusion based cancers.
Latest Patents
Iavarone's latest patents include innovative methods related to fusion proteins. One of his notable inventions discloses oncogenic fusion proteins and provides methods for treating gene-fusion based cancers. This groundbreaking work aims to advance therapeutic strategies for patients affected by these specific types of cancers.
Career Highlights
Throughout his career, Antonio Iavarone has been associated with prestigious institutions, including Columbia University. His research has garnered attention for its potential to transform cancer treatment and improve patient outcomes.
Collaborations
Iavarone has collaborated with esteemed colleagues such as Anna Lasorella and Raul Rabadan. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field of oncology.
Conclusion
Antonio Iavarone's innovative work in oncogenic fusion proteins exemplifies the critical role of inventors in advancing medical science. His contributions are paving the way for new treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile